US2021179625A1PendingUtilityA1

Aryl hydrocarbon receptor antagonists and uses thereof

68
Assignee: MAGENTA THERAPEUTICS INCPriority: Apr 12, 2017Filed: Dec 18, 2020Published: Jun 17, 2021
Est. expiryApr 12, 2037(~10.7 yrs left)· nominal 20-yr term from priority
C12N 2501/999C12N 5/0647A61P 25/16A61P 25/14A61P 21/04A61P 13/10A61P 7/06A61P 5/14A61K 2035/124A61K 35/28A61P 37/00A61P 25/28A61P 25/08A61P 17/00A61P 7/00A61P 37/02A61P 35/02A61P 21/00A61P 19/00A61P 9/10A61P 3/00A61P 1/00C07D 519/00C07D 487/04C07D 471/04A61P 43/00A61P 35/00A61P 25/00A61P 19/02A61P 15/00A61P 1/16Y02A50/30A61K 31/437A61K 31/4985
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The disclosure relates to aryl hydrocarbon receptor antagonists, such as substituted imidazopyridines and imidazopyrazines, as well as methods of expanding hematopoietic stem cells by culturing hematopoietic stem or progenitor cells in the presence of these agents. Additionally, the disclosure provides methods of treating various pathologies in a patient by administration of expanded hematopoietic stem cells. The disclosure further provides methods of synthesizing aryl hydrocarbon receptor antagonists, such as substituted imidazopyridines and imidazopyrazines, as well as kits containing aryl hydrocarbon receptor antagonists that can be used for the expansion of hematopoietic stem cells.

Claims

exact text as granted — not AI-modified
1 . A compound selected from the group consisting of 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         and salts thereof. 
       
     
     
         2 . The compound of  claim 1 , wherein the compound is compound (12) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         3 . The compound of  claim 1 , wherein the compound is compound (13) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         4 . The compound of  claim 1 , wherein the compound is compound (14) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         5 . The compound of  claim 1 , wherein the compound is compound (15) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         6 . The compound of  claim 1 , wherein the compound is compound (16) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         7 . The compound of  claim 1 , wherein the compound is compound (17) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         8 . The compound of  claim 1 , wherein the compound is compound (18) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         9 . The compound of  claim 1 , wherein the compound is compound (19) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         10 . The compound of  claim 1 , wherein the compound is compound (20) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         11 . The compound of  claim 1 , wherein the compound is compound (21) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         12 . The compound of  claim 1 , wherein the compound is compound (22) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         13 . The compound of  claim 1 , wherein the compound is compound (23) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         14 . The compound of  claim 1 , wherein the compound is compound (24) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         15 . The compound of  claim 1 , wherein the compound is compound (25) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         16 . The compound of  claim 1 , wherein the compound is compound (26) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         17 . The compound of  claim 1 , wherein the compound is compound (27) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         18 . The compound of  claim 1 , wherein the compound is compound (28) 
       
         
           
           
               
               
           
         
         or a salt thereof. 
       
     
     
         19 . A method of producing an expanded population of hematopoietic stem cells ex vivo, comprising contacting a population of hematopoietic stem cells with the compound of  claim 1 . 
     
     
         20 . A method of treating a disorder in a subject in need thereof comprising administering to the subject a pharmaceutically effective amount of the expanded population of hematopoietic stem cells being prepared by the method of  claim 19 .

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.